Objective We investigated the benefit of Impella, a modern percutaneous mechanical support (pMCS) device, versus former standard intra-aortic balloon pump (IABP) in acute myocardial infarction ...

The Impella device (Impella, Abiomed, Danvers ... ECP, Expandable percutaneous heart pump; eGFR, estimated glomerular filtration rate; hs-TnT, high-sensitivity cardiac Troponin T; INTERMACS, ...

at Rainbow Children's Heart Institute, has earned a United States patent for his breakthrough innovation, the KONAR-MF (Multifunctional) Occluder, a device designed to close septal defects in children ...

Female shock patients face delays in treatment and are less likely to receive approved interventions, says Suzanne Baron.

A Hyderabad-based doctor has received a United States patent for his innovative medical device designed to close septal defects ... Division of Pediatric Cardiology at Rainbow Children’s Heart ...

marked a significant milestone in cardiovascular care with the successful transcatheter device occlusion of a patent ductus arteriosus (PDA) in an adult patient with congenital heart disease — a ...

marked a significant milestone in cardiovascular care with the successful transcatheter device occlusion of a patent ductus arteriosus (PDA) in an adult patient with congenital heart disease - a first ...

Aortic Stenosis is one of the most serious and common heart valve diseases ... "Receiving FDA Breakthrough Device Designation marks another significant milestone for HeartSciences," said Andrew ...

Officials said, "An Impella heart pump is a temporary artificial heart pump that supports a patient’s circulatory system during procedures or when the heart’s pumping function is compromised.

Lang and teammates Alexi Pierre-Louis, Sam Wu, Jonathan Makhoul, Sumin Jeong and Alice Tian developed a device that holds and stabilizes an intracardiac echocardiography catheter during heart ...

The British Heart Foundation said more than a million people in the UK had heart failure An at-home 'foot-recognition' scanner could prevent heart failure hospitalisations, a study has found.